LENZ Therapeutics, Inc.
LENZ
$28.88
$0.3651.28%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 44.09% | -12.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 17.61% | -9.80% | |||
| Operating Income | -17.61% | 9.80% | |||
| Income Before Tax | -23.85% | 0.38% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -23.86% | 0.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -23.86% | 0.38% | |||
| EBIT | -17.61% | 9.80% | |||
| EBITDA | -17.51% | 9.76% | |||
| EPS Basic | -22.43% | 6.12% | |||
| Normalized Basic EPS | -22.38% | 6.11% | |||
| EPS Diluted | -22.43% | 6.12% | |||
| Normalized Diluted EPS | -22.38% | 6.11% | |||
| Average Basic Shares Outstanding | 1.18% | 6.11% | |||
| Average Diluted Shares Outstanding | 1.18% | 6.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||